Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Third time is a charm for Atossa Genetics: company finally completes IPO

Executive Summary

Two years after its first filing attempt (and two subsequent withdrawals), molecular diagnostics start-up Atossa Genetics Inc. has finally gone public netting $3.7mm by selling 800k shares at $5 apiece.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Services
  • Medical Devices
    • Diagnostic Equipment & Supplies
  • In Vitro Diagnostics
    • Cytology
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies